CardiacSense said it was also in the process of receiving FDA and CEO regulatory approvals for marketing in the United States and EuropeIsrael's CardiacSense said on Sunday it signed a $32.4 million deal to sell medical watches in India, bringing its total backlog of orders to over $60 million.
The company said the agreement is for 150,000 watches - which can monitor vital signs like temperature, blood pressure and blood oxygen saturation - to be used in hospitals, home hospitalisations and patient monitoring.
FII sentiment shows early signs of turnaround after months of selling: Report
UPI should remain free: Expert on why MDR could push merchants and consumers back to cash
Apple job cuts 2026: iPhone maker slashes 200 jobs in Siri, Vision Pro immersive video, gaming teams
'Last-minute changes unfair, uneconomic': US-Canada trade talks collapse as Trump readies 50% tariffs on Canadian products
The $1.8 trillion space economy: Who will capture value as the final frontier goes commercial?
Meta’s $200 Billion Trial: Did Instagram & Facebook Keep Kids Hooked?
Motor Insurance Explained: Is Third-Party Car Insurance Enough? Know Before You Buy
Retirement Tax Planning: 5 Ways Senior Citizens Can Reduce Their Tax Liability
#IndiaAt100 : Adipen Bose Nandhiji On Conscious Capitalism- Can Profit & Purpose Coexist?
#IndiaAt100 : Hisashi Takeuchi On Driving India’s Manufacturing Revolution
Gaja Alternative Assets IPO: 3 ways to check application status; allotment odds, GMP, listing dateFII sentiment shows early signs of turnaround after months of selling: Report
₹24,800 crore bill: How transaction costs are eating into retail derivatives trading
Cupid, NTPC Green, NTPC, Raymond Realty, HAL shares: Key technical levels to watch
Defence stock with Rs 2,654-crore order book hits record high; here's why 
India’s AI bet goes global: 93% of businesses trust AI with data, 87% eye new markets
US/UK citizenship and PPF: What happens to your Indian savings after naturalisation?
The Rs 606 problem: What happens when India puts a price on UPIUPI should remain free: Expert on why MDR could push merchants and consumers back to cash
'Before 2019, my son had to change school every year': Maharashtra FDA boss Tukaram Mundhe of 25 transfers in 21 years
